MD, PhD, Professor of Orthopaedic Surgery. An internationally recognized orthopaedic surgeon, recognized for his pioneering research in the 1990s at the University of Oulu, prior to founding BBS in 2003. Jalovaara has published extensively in the field of orthopaedics and has a strong professional network.

MSc in Economics. CEO and partner of Fortel Management Oy through which he has been involved in venture capital operations since 1998. Four of Fortel’s portfolio companies have been successfully listed on Nasdaq OMX Helsinki. Säynäjäkangas has been a board member in more than 25 venture capital and technology companies.

PhD in Medical Engineering. Tölli has extensive experience of biomaterials and bone graft substitutes having been with BBS since 2006 and after conducting her PhD thesis concerning the BBS product.

MSc in Chemistry. Haikola has 27 years of experience in the pharmaceutical industry and product development, quality control, quality assurance and GMP compliance. Prior to joining BBS in 2006, she worked for Leiras Schering Oy and Focus Inhalation Oy in 1988-2003, and CTT-Cancer Targeting Technologies Oy in 2003-2006. Post graduate studies in industrial pharmacy and in pharmaceutical technology (2004 -).

M.Sc. (Biochem. Eng.) Joined BBS in 2006. Has participated in several research projects in the Universities of Oulu and Helsinki, where he gained his special know-how in fermentation processes, protein chemistry and analytical methods, especially immunological methods.

M.Sc. (Pharm.) Taube-Siikavirta has over 20 years of experience within clinical research and two years of experience within automated dose dispensing. Previous experience includes: Project Manager, Oy Medfiles Ltd (CRO), 1999-2006; Project Director, Oy Medfiles Ltd (CRO), 2006-2010; Pharmacist, Responsible Person, Pharmados Oy, Oulu, Finland JUN2014-JUL2014; and Clinical Research Director, Oy Medfiles Ltd, Oulu, Finland MAR2014-ongoing.

M.Sc. Chem. Joined BBS in 2007. Has 14 years of experience in the pharmaceutical industry (Leiras Schering AG, Focus Inhalation Oy, LAB Pharma Oy, 1994 - 2007), as a senior scientist in the inhalation technology product development, in the area of Chemistry, Manufacturing and Control (CMC).

M.Sc. (Biol.), PhD. Joined BBS Ltd in 1999. Has completed her doctorate thesis in the field of molecular genetics and biology at the University of Bielefeld, Germany. As part of her research, Dr. Birr developed a method for isolating the enzyme lysozyme from bacteria, patented by Hoechst AG and used in the food industry. Has been a Researcher at the University of Oulu since 1993, where she has been studying the morphogenic proteins of reindeer.